Research Imaging Centre

Centre for Addiction and Mental Health (CAMH), Toronto, Ontario
What the facility does

Neuroimaging research on psychiatric and neurological disorders using Positron-Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) scanning

Area(s) of Expertise

The Centre for Addiction and Mental Health (CAMH) Research Imaging Centre is one of the few brain-imaging facilities that is fully dedicated to research on mental illness and addictions, offering both Positron-Emission Tomography (PET) and MRI imaging. In the past 20 years, CAMH PET research has yielded major discoveries that have been applied to clinical treatment and drug development and have led to the creation of widely used radiotracers.

Research Services

Positron-Emission Tomography (PET) neuroimaging, MR neuroimaging including DTI (Diffusion Tensor Imaging), Magnetic Resonance Spectroscopy (MRS) Imaging-genetics

Sectors of Application
  • Healthcare and social services
  • Life sciences, pharmaceuticals and medical equipment

Equipment

Function

Scanditronix MC-17F cyclotron

 

IBA Cyclone 18 twin high-current cyclotron

 

Two radiochemistry laboratories with 17 hot cells for radiosynthesis; quality-control laboratory

Radiosynthesis of Positron-Emission Tomography (PET) radiotracers for imaging and development of new PET probes for brain research

Siemens High-Resolution Research Tomograph (HRRT) scanner

Brain high-resolution PET imaging

Siemen s Biograph-16 PET/CT scanner

Whole-body PET/CT imaging

GE MR750 3-Tesla MRI scanner

Anatomical, functional and spectroscopic imaging

Scansys carbon-11 carbon-monoxide modules

Automated radiosynthesis modules for radiopharmaceutical production for routine human use and applications, radiochemistry R&D and preclinical doses

GE TRACERlab FXFN Pro modules

Automated radiosynthesis modules for radiopharmaceutical production for routine human use and applications, radiochemistry R&D and preclinical doses

Agilent High Performance Liquid Chromatography (HPLC) systems

Quality control of radiopharmaceuticals and the research and development of radiopharmaceutical compounds